________________
Just Published
|
________________
hTEE In the News
The Medical Center of Central Georgia Announces New Advanced Monitoring System
MACON, GA - (September 6, 2012) The Medical Center of Central Georgia (MCCG) is pleased to announce the addition of a first-of-its-kind medical device to guide the identification and management of compromised blood flow in critically ill patients.
MCCG has added the ImaCor hTEE™ system to its Cardiovascular and Surgical Trauma Intensive Care Units (CVICU and STICU) to allow physicians to view the heart function of critical patients in real time.
To Read More, Click Here
|
The Daily Dose @Jefferson Blog
August 9, 2012
For critically ill patients, it is important for physicians to monitor how the heart is functioning in real-time.
A new device is allowing surgeons at Jefferson University Hospitals to monitor patients' complete cardiac function without the need to transport them from their hospital rooms.
|
_______________
hTEE Evening Symposium
Interested in attending the hTEE Symposium in Portugal on October 14?
Space is limited so please contact us at press@imacorinc.com to reserve your spot.
|
|
HAI 2012
September 13-15, 2012
Berlin, Germany
|
SOCCA Annual Meeting
October 11 - 12, 2012 Washington, DC, USA |
 Photos |
Our next generation Zura EVO being used at CHU Ambroise Pare by Antoine Vieillard-Baron MD PhD (right) and Cyril Charron MD PhD (left) while Nic Heron of ImaCor looks on.
|
Michelle Gardecki MD from Thomas Jefferson University (TJU) Hospital orienting a ClariTEE probe in ImaCor's state-of-the-art simulator during hTEE training.
|
 Jacqueline Urtecho MD from TJU Neuro ICU assessing patient cardiac filling and function.
|
_______________
Defining hTEE
Our revolutionary technology defined a new kind of TEE
-hemodynamic TEE -
to reflect the unique application of our miniaturized, disposable ClariTEE probe that provides TEE imaging while remaining indwelling for up to 72 hours.
 (click to enlarge)
|
|
____________________
Clinical Training Pathway
The ImaCor hTEE Clinical Training Pathway (CTP) is a 5-step program designed to help TEE and non-TEE trained users master hTEE simply and effectively.
|
|
_____________________
Contact Us
|
|
|
|
hTEE in the Neuro ICU Jacqueline Urtecho MD, Assistant Professor of Neurosurgery and Neurology, Thomas Jefferson University Hospital
"The biggest advantage to implementing hTEE for a Neuro ICU is ease of use and quickness of evaluation for volume..."
|
Clinical Utility of Miniaturized Transesophageal Imaging in a Trauma Patient with Right Ventricular Rupture
Benjamin Kohl MD, Chief of Critical Care Division, Hospital of the University of Pennsylvania
 A 41-year-old female presented to the ER following an
MVA. She had a remarkable history of orthotopic heart
transplant 10 years prior. One week prior to admission,
she developed an acute coronary syndrome, which required percutaneous coronary intervention. Upon examination, she was found to have multiple orthopedic injuries as well as bilateral cerebral contusions. Given the nature of the blunt trauma, computed tomography (CT) of the chest was ordered. Results showed RV freewall discontinuity consistent with RV rupture that appeared contained within the thorax.
. . .Surgical repair could not be performed immediately due to treatment of concomitant cerebral contusions with anticoagulation therapy. Insertion of a pulmonary artery (PA) catheter poses a risk of systemic bleeding during anticoagulation therapy, therefore was not performed. Given the importance of structural and hemodynamic information needed to determine the course of treatment in a high risk, preoperative patient, hTEE imaging was superior for imaging of the patient's right heart function. Importantly, hTEE does not interfere with anticoagulation therapy and can be indwelling for up to 72 hours.
 | Day 1: Assessment of
Biventricular
Function |
 | | Day 2: Second Assessment of Biventricular Function |
|
hTEE Cost Justification Model
(Case Studies)
Making the Right Decision Clinically and Financially
The reason for choosing ImaCor to manage your hemodynamically unstable patients is quite compelling: with 20% of ICU patients generating 80% of ICU costs, evidence shows hTEE leads to improved outcomes and decreased costs when applied to these highest-acuity patients. To see how three institutions have verified this, click the image below.
(click to enlarge)
|
hTEE Integrated into Unit Protocols
Wake Forest University Baptist Medical Center, University of Alabama at Birmingham Hospital (UAB), Columbia University Medical Center and Thomas Jefferson University Hospital are among the hospitals that have incorporated hTEE into their post-op cardiac and/or trauma patient protocols. The following is an example of one such protocol, developed and used at UAB's Trauma/Burn ICU.
|
Pressors - Yes or No? How hTEE Can Help Harold M. Hastings PhD, ImaCor Inc.
(Excerpted, please click to read full report)
A recent 2,332 patient study from Harvard-MIT, Mount Sinai, NYU, and Beth Israel Deaconess (Lee J, Kothari R, Ladapo JA, Scott DJ, Celi LA, Interrogating a clinical database to study treatment of hypotension in the critically ill. BMJ Open 2012;2:e000916 doi:10.1136/bmjopen-2012-000916) clearly evaluates the role of pressors and their potential side effects. We present here the high points of that study, a link to the study and abstract, and some thoughts about the role of hTEE. A patient presents with hypotension or is at risk for hypotension following surgery, trauma, or sepsis. Administer volume, inotropes, pressors, a combination? Here are the main results: 
Read More    
Lee J, Kothari R, Ladapo JA, Scott DJ, Celi LA. Interrogating a clinical database to study treatment of hypotension in the critically ill. BMJ Open 2012;2:e000916 doi:10.1136/bmjopen-2012-000916 - click here |
 As we head into the Fall, we are focused on delivering to all customers the tremendous developments we have achieved this year. We continue to refine our process and to advance our technologies to provide unique solutions for critical care. Our clinical specialists are focused on new installations throughout the US and Europe including Henry Ford, Mayo Clinic, Charite-Universitaetsmedizin Berlin, and Hospital Sao Jose in Lisbon. Equally impactful, our advanced solutions prove to be extremely beneficial to our users' workflow. We realize the compelling evidence that 20% of ICU patients are generating 80% of unit costs. As an essential critical care resource and part of our users' high acuity escalation plans, hTEE is optimizing hemodynamic therapies to reduce these costs. Our technology is playing an integral role as physicians identify specific clinical indicators of potential complications and establish protocols to address them. The paradigm is changing in the field of hemodynamic management. While we bring you a myriad of educational opportunities this Fall, know our focus is years ahead. Join us at the hTEE Lisbon Symposium, where world-renowned physicians in critical care will present their clinical evidence, and learn about this revolutionary approach for your sickest patients. With warmest regards, Peter Pellerito President and CEO |
|
|
|
|
